Pascal Lebray

7.2k total citations · 2 hit papers
78 papers, 3.1k citations indexed

About

Pascal Lebray is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Pascal Lebray has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 55 papers in Hepatology and 15 papers in Surgery. Recurrent topics in Pascal Lebray's work include Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (36 papers) and Hepatitis B Virus Studies (26 papers). Pascal Lebray is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (36 papers) and Hepatitis B Virus Studies (26 papers). Pascal Lebray collaborates with scholars based in France, United States and Germany. Pascal Lebray's co-authors include Vlad Ratziu, Thierry Poynard, Dominique Thabut, Frédéric Charlotte, Raluca Pais, J. Moussalli, M. Munteanu, Thierry Poynard, Pierre Bédossa and Yen Ngo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Pascal Lebray

74 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

2013 380 citations Raluca Pais, Frédéric Charlotte et al. Journal of Hepatology profile →
NAFLD and liver transplantation: Current burden and expected challenges

2016 320 citations Raluca Pais, A. Sidney Barritt et al. Journal of Hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Pascal Lebray	2.5k	2.1k	451	429	252	78	3.1k
Michael Adler	1.8k 0.7×	1.7k 0.8×	385 0.9×	716 1.7×	282 1.1×	81	3.1k
Takashi Nakahara	950 0.4×	946 0.5×	164 0.4×	289 0.7×	172 0.7×	118	1.9k
Emanuel K. Manesis	2.5k 1.0×	2.3k 1.1×	167 0.4×	185 0.4×	85 0.3×	80	3.0k
Jörg Bojunga	838 0.3×	549 0.3×	672 1.5×	577 1.3×	323 1.3×	112	2.3k
Munther J. Hussain	1.2k 0.5×	1.3k 0.6×	219 0.5×	528 1.2×	82 0.3×	57	2.4k
Cem Kalaycı	874 0.3×	558 0.3×	304 0.7×	712 1.7×	145 0.6×	50	1.9k
Jeffery L. Steers	1.0k 0.4×	1.3k 0.6×	218 0.5×	1.1k 2.7×	90 0.4×	64	2.3k
Hisamitsu Miyaaki	965 0.4×	994 0.5×	116 0.3×	393 0.9×	115 0.5×	145	2.1k
Juan A. del Olmo	1.7k 0.7×	2.1k 1.0×	70 0.2×	846 2.0×	132 0.5×	49	2.9k
Naota Taura	847 0.3×	726 0.4×	138 0.3×	294 0.7×	71 0.3×	87	1.6k

Countries citing papers authored by Pascal Lebray

Since Specialization

Citations

This map shows the geographic impact of Pascal Lebray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Lebray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Lebray more than expected).

Fields of papers citing papers by Pascal Lebray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Lebray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Lebray. The network helps show where Pascal Lebray may publish in the future.

Co-authorship network of co-authors of Pascal Lebray

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Lebray. A scholar is included among the top collaborators of Pascal Lebray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Lebray. Pascal Lebray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stern, Christiane, et al.. (2023). Low-phospholipid associated cholelithiasis (LPAC) syndrome: an unusual form in an elderly and overweight woman. SHILAP Revista de lepidopterología. 13(1).

Rushakoff, Joshua A., Alexander Kuo, Patrick Botting, et al.. (2023). Utility of a score-based approach to liver assessment in heart transplant candidates. SHILAP Revista de lepidopterología. 4. 100045–100045.

Coilly, Audrey, Mylène Sebagh, Claire Fougerou‐Leurent, et al.. (2022). HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation. Clinics and Research in Hepatology and Gastroenterology. 46(9). 102024–102024.

Allaire, Manon, et al.. (2021). “De novo” cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!. Clinics and Research in Hepatology and Gastroenterology. 46(4). 101827–101827.

Eyraud, Daniel, Ludovic Suner, Axelle Dupont, et al.. (2018). Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. PLoS ONE. 13(8). e0200364–e0200364. 9 indexed citations

Nguyen, Thuy, Sepideh Akhavan, Fabienne Caby, et al.. (2018). Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing. International Journal of Antimicrobial Agents. 53(1). 80–83. 7 indexed citations

Weiss, Nicolas, Fanny Mochel, Marika Rudler, et al.. (2017). Peak hyperammonemia and atypical acute liver failure: The eruption of an urea cycle disorder during hyperemesis gravidarum. Journal of Hepatology. 68(1). 185–192. 23 indexed citations

Lebray, Pascal, et al.. (2017). Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France. Value in Health. 20(9). A783–A783. 2 indexed citations

Pais, Raluca, A. Sidney Barritt, Yvon Calmus, et al.. (2016). NAFLD and liver transplantation: Current burden and expected challenges. Journal of Hepatology. 65(6). 1245–1257. 320 indexed citations breakdown →

10.

Perazzo, Hugo, Raluca Pais, M. Munteanu, et al.. (2014). Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?”. Clinics and Research in Hepatology and Gastroenterology. 38(4). 432–439. 5 indexed citations

11.

Pais, Raluca, Pascal Lebray, G. Rousseau, et al.. (2014). Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Associated Cirrhosis Awaiting Liver Transplants. Clinical Gastroenterology and Hepatology. 13(5). 992–999.e2. 20 indexed citations

12.

Perazzo, Hugo, M. Munteanu, Yen Ngo, et al.. (2014). Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia. Alimentary Pharmacology & Therapeutics. 40(9). 1081–1093. 25 indexed citations

13.

Fontaine, H., Cyrille Chazallon, Maryline Bourgine, et al.. (2011). 1367 RELAPSE AFTER ANALOGUES TREATMENT DISCONTINUATION IS NOT PREVENTED BY DNA VACCINATION IN CHRONIC HEPATITIS B (ANRS HB 02 VAC-ADN). Journal of Hepatology. 54. S542–S542. 3 indexed citations

14.

Mallet, Vincent, Alexandre Louvet, Pascal Lebray, et al.. (2011). 1254 RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS E: A CASE-SERIES. Journal of Hepatology. 54. S495–S495. 8 indexed citations

15.

Poynard, Thierry, Julien Massard, Marika Rudler, et al.. (2009). Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: An overview of published trials. Gastroentérologie Clinique et Biologique. 33(10-11). 916–922. 14 indexed citations

16.

Prisant, Nadia, Roland Tubiana, Gilles Lefèbvre, et al.. (2009). HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome. Fertility and Sterility. 93(3). 1020–1023. 28 indexed citations

17.

Poynard, Thierry, Yen Ngo, Françoise Imbert‐Bismut, et al.. (2008). Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroentérologie Clinique et Biologique. 32(6). 8–21. 34 indexed citations

18.

Ngo, Yen, Yves Benhamou, Vincent Thibault, et al.. (2008). An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load. PLoS ONE. 3(7). e2573–e2573. 58 indexed citations

19.

Lebray, Pascal, H. Zylberberg, Sophie Hüe, et al.. (2004). Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C. Journal of Viral Hepatitis. 11(2). 175–182. 40 indexed citations

20.

Lebray, Pascal, Anaïs Vallet‐Pichard, Marie‐Louise Michel, et al.. (2003). Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection. Journal of Hepatology. 39. 151–159. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact